GSK Scores Key Win as Hansoh's Lung Cancer Drug Meets Phase III Survival Goal sheeba farhat11 July 2026 6:15 PM ISTLondon: GSK said on Friday that partner Hansoh Pharmaceutical's experimental drug for advanced small-cell lung cancer met its main goal of...
FDA Advisory Panel Backs Moderna's mRNA Flu Vaccine for Adults Aged 50 and Older sheeba farhat21 Jun 2026 10:15 AM ISTBengaluru: Advisers to the U.S. Food and Drug Administration on Thursday backed approval of Moderna's flu vaccine for adults aged 50 and older, saying...
USFDA Approves GSK's Utebzi, First Oral Carbapenem for Complicated Urinary Tract Infections sheeba farhat20 Jun 2026 8:40 PM ISTNew Delhi: The U.S. FDA has approved GSK's oral antibiotic to treat complicated urinary tract infections, the regulator said on Wednesday, giving...
CALPOL a Well-Known Trademark: Delhi HC Bars WALPOL Use, Awards Rs 2 Lakh Damages to GSK Susmita Roy20 May 2026 5:15 PM ISTNew Delhi: The Delhi High Court has declared CALPOL, the widely used medicinal brand owned by GlaxoSmithKline Pharmaceuticals Limited, (GSK) as a...
Bristol Myers Squibb, China's Hengrui Sign USD 15.2 Billion Drug Collaboration Deal MD Bureau14 May 2026 8:14 PM ISTNew Delhi: Jiangsu Hengrui Pharmaceuticals, China's biggest drugmaker by market value, on Tuesday said it struck global collaboration and licensing...
GSK's Efimosfermin Secures USFDA Breakthrough, EMA PRIME Tags for MASH sheeba farhat28 April 2026 7:54 PM ISTLondon: GlaxoSmithKline plc (GSK) has announced that its investigational liver therapy efimosfermin has received both Breakthrough Therapy Designation...
GSK's Mo-rez Shows Strong Tumor Reduction Data, Tipped as Potential Blockbuster Cancer Drug sheeba farhat14 April 2026 8:07 PM ISTLondon: British drugmaker GSK's experimental targeted cancer drug Mo-rez has blockbuster potential, its head of oncology research has told...
FDA Approves First Drug for Cholestatic Pruritus in Primary Biliary Cholangitis Dr. Kamal Kant Kohli22 March 2026 8:45 PM ISTThe U.S. Food and Drug Administration has approved linerixibat, marking the first treatment specifically indicated for cholestatic pruritus in...
GSK Gets USFDA Nod for Liver Disease-Related Itching Drug Lynavoy sheeba farhat20 March 2026 11:26 PM ISTLondon: The U.S. Food and Drug Administration approved GSK's drug for severe relentless itching caused by a type of liver disease, the company said...
FDA Expands Approval of GSK's RSV Vaccine to At-Risk Adults Aged 18-49 Dr. Kamal Kant Kohli15 March 2026 8:45 PM ISTThe U.S. Food and Drug Administration has expanded the approved use of Arexvy, an RSV vaccine developed by GSK, to include adults aged 18 to 49 who...
USFDA Expands Use of GSK's RSV Vaccine Arexvy to Adults 18-49 at Risk sheeba farhat14 March 2026 10:30 AM ISTBengaluru: British drugmaker GSK said on Friday the U.S. Food and Drug Administration has expanded the approved age range for its respiratory...
GSK Licenses Linerixibat to Alfasigma in Deal Worth Up to USD 690 Million sheeba farhat10 March 2026 11:03 PM ISTBengaluru: GSK said on Monday it will receive up to USD 690 million from Italian pharmaceutical company Alfasigma for the worldwide rights to...
